Clinical Trial Update: Protection From Cisplatin Ototoxicity by Lactated Ringers [Phase 1]

View source ↗

Summary

Phase 1 trial investigating protection from cisplatin-induced ototoxicity using Lactated Ringer's solution. The study has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss

Drugs mentioned

• Lactated Ringer's solution (Ringer's lactate solution)

Snippet

Sponsor: University of Oklahoma | Conditions: Hearing Loss | Phase 1 | Status: WITHDRAWN